Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 45 (RPL12P45)

Target: RPL12P45
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L12 pseudogene 45 (RPL12P45) is a pseudogene in the human genome, named for its sequence homology to the functional ribosomal protein L12 gene (RPL12) but lacking coding potential for a functional protein. Such pseudogenes arise from duplications or retrotranspositions of the original gene and are typically nonfunctional due to mutations, truncations, or absence of regulatory elements. There is no evidence that RPL12P45 encodes a protein or plays a direct role in cellular physiology, human disease, or pharmacology[2][9]. It serves as a genomic relic with no known biological or therapeutic function.

Other names: RPL12P45

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 45 (RPL12P45).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 45 (RPL12P45).

Explore the full profile